» Articles » PMID: 25935743

High-resolution Pulmonary Ventilation and Perfusion PET/CT Allows for Functionally Adapted Intensity Modulated Radiotherapy in Lung Cancer

Overview
Journal Radiother Oncol
Specialties Oncology
Radiology
Date 2015 May 4
PMID 25935743
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: To assess the utility of functional lung avoidance using IMRT informed by four-dimensional (4D) ventilation/perfusion (V/Q) PET/CT.

Materials And Methods: In a prospective clinical trial, patients with non-small cell lung cancer (NSCLC) underwent 4D-V/Q PET/CT scanning before 60Gy of definitive chemoradiation. Both "highly perfused" (HPLung) and "highly ventilated" (HVLung) lung volumes were delineated using a 70th centile SUV threshold, and a "ventilated lung volume" (VLung) was created using a 50th centile SUV threshold. For each patient four IMRT plans were created, optimised to the anatomical lung, HPLung, HVLung and VLung volumes, respectively. Improvements in functional dose volumetrics when optimising to functional volumes were assessed using mean lung dose (MLD), V5, V10, V20, V30, V40, V50 and V60 parameters.

Results: The study cohort consisted of 20 patients with 80 IMRT plans. Plans optimised to HPLung resulted in a significant reduction of functional MLD by a mean of 13.0% (1.7Gy), p=0.02. Functional V5, V10 and V20 were improved by 13.2%, 7.3% and 3.8% respectively (p-values<0.04). There was no significant sparing of dose to functional lung when adapting to VLung or HVLung. Plan quality was highly consistent with a mean PTV D95 and D5 ranging from 60.8Gy to 61.0Gy and 63.4Gy to 64.5Gy, respectively, and mean conformity and heterogeneity index ranging from 1.11 to 1.17 and 0.94 to 0.95, respectively.

Conclusion: IMRT plans adapted to perfused but not ventilated lung on 4D-V/Q PET/CT allowed for reduced dose to functional lung whilst maintaining consistent plan quality.

Citing Articles

A review on functional lung avoidance radiotherapy plan for lung cancer.

Yu J, Tang X, Lei Y, Zhang Z, Li B, Bai H Front Oncol. 2024; 14:1429837.

PMID: 39703855 PMC: 11656049. DOI: 10.3389/fonc.2024.1429837.


Conference Report: Review of Clinical Implementation of Advanced Quantitative Imaging Techniques for Personalized Radiotherapy.

Vinogradskiy Y, Bahig H, Bucknell N, Buchsbaum J, Shu H Tomography. 2024; 10(11):1798-1813.

PMID: 39590941 PMC: 11598114. DOI: 10.3390/tomography10110132.


Fully Automated Ga-Labeling and Purification of Macroaggregated Albumin Particles for Lung Perfusion PET Imaging.

Blanc-Beguin F, Masset J, Robin P, Tripier R, Hennebicq S, Guilloux V Front Nucl Med. 2024; 1:778191.

PMID: 39355632 PMC: 11440869. DOI: 10.3389/fnume.2021.778191.


Harnessing the Power of Radiotherapy for Lung Cancer: A Narrative Review of the Evolving Role of Magnetic Resonance Imaging Guidance.

Cheng S, Lee S, Lee H Cancers (Basel). 2024; 16(15).

PMID: 39123438 PMC: 11311467. DOI: 10.3390/cancers16152710.


Incorporation of Functional Lung Imaging Into Radiation Therapy Planning in Patients With Lung Cancer: A Systematic Review and Meta-Analysis.

Midroni J, Salunkhe R, Liu Z, Chow R, Boldt G, Palma D Int J Radiat Oncol Biol Phys. 2024; 120(2):370-408.

PMID: 38631538 PMC: 11580018. DOI: 10.1016/j.ijrobp.2024.04.001.